Brief: Enliven Therapeutics Announces Proposed Public Offering Of Common Stock
13/06/2025 12:00
June 13 (Reuters) - Enliven Therapeutics Inc ELVN.O: ENLIVEN THERAPEUTICS ANNOUNCES PROPOSED PUBLIC OFFERING OF COMMON STOCK AND PRE-FUNDED WARRANTS ENLIVEN THERAPEUTICS INC - ANNOUNCES $200 MILLION PUBLIC OFFERING Source text: ID:nPn4QyL3La Further company coverage: ELVN.O ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Enliven Therapeutics
See all newsBrief: Enliven Therapeutics Appoints Kristine Ball To Board Of Directors Ahead Of Planned Phase 3 Trial Initiation This Year
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
U.S. RESEARCH ROUNDUP-Caterpillar, Eli Lilly, McKesson
Enliven Therapeutics Q2 net loss widens on higher expenses